These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23019238)

  • 1. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
    Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
    Fang JH; Yu XM; Zhang SH; Yang Y
    J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
    Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
    Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
    Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
    McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
    Remschmidt C; Kaufmann AM; Hagemann I; Vartazarova E; Wichmann O; Deleré Y
    Int J Gynecol Cancer; 2013 Mar; 23(3):519-26. PubMed ID: 23360813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up.
    Jensen KE; Schmiedel S; Norrild B; Frederiksen K; Iftner T; Kjaer SK
    Br J Cancer; 2013 Jan; 108(1):234-9. PubMed ID: 23169283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse.
    Feng RM; Hu SY; Zhao FH; Zhang R; Zhang X; Wallach AI; Qiao YL
    J Gynecol Oncol; 2017 Sep; 28(5):e47. PubMed ID: 28657217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
    J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 18. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
    Baandrup L; Munk C; Andersen KK; Junge J; Iftner T; Kjær SK
    Gynecol Oncol; 2012 Feb; 124(2):281-5. PubMed ID: 22036987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
    Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Lie AK; Tropé A; Skare GB; Bjørge T; Jonassen CM; Brusegard K; Lönnberg S
    Gynecol Oncol; 2018 Jan; 148(1):111-117. PubMed ID: 29132873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.